scholarly article | Q13442814 |
P2093 | author name string | Sheila Aparecida Coelho Siqueira | |
Marcel Cerqueira Cesar Machado | |||
Delmar Muniz Lourenço | |||
Marcelo Augusto Cortina Gonçalves dos Santos | |||
Fabio Luiz de Menezes Montenegro | |||
Rodrigo Almeida Toledo | |||
Sergio Pereira Almeida Toledo | |||
Flavia Lima Coutinho | |||
Leontina Conceição Margarido | |||
P433 | issue | 4 | |
P921 | main subject | multiple endocrine neoplasia | Q1553018 |
multiple endocrine neoplasia type 1 | Q3347154 | ||
P304 | page(s) | 465-476 | |
P577 | publication date | 2007-08-01 | |
P1433 | published in | Clinics | Q26841864 |
P1476 | title | The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1 | |
P478 | volume | 62 |
Q37023603 | A differential diagnosis of inherited endocrine tumors and their tumor counterparts |
Q35897668 | Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1. |
Q37808142 | Care for patients with multiple endocrine neoplasia type 1: the current evidence base |
Q37056120 | Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors |
Q64120689 | Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism? |
Q94464331 | Editorial: Early Genetic and Clinical Diagnosis in MEN1 |
Q39129029 | Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old. |
Q90290355 | Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1 |
Q35813450 | Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice |
Q37629658 | Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group |
Q37261277 | Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma |
Q51336795 | Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary? |
Q33822855 | Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis |
Q36192096 | MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients |
Q35895509 | Narrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in Brazil |
Q35895460 | Pituitary tumors in patients with MEN1 syndrome. |
Q35895464 | Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1. |
Q49154597 | Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism. |
Q33458398 | Sporadic medullary thyroid carcinoma: clinical data from a university hospital |
Q35895469 | Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2. |
Q27026980 | Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 |
Q58750857 | The Importance of an Early and Accurate MEN1 Diagnosis |
Q35895519 | Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center |
Q38852179 | Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients |
Search more.